198 related articles for article (PubMed ID: 29576753)
1. Autoimmune Retinopathy: Current Concepts and Practices (An American Ophthalmological Society Thesis).
Sen HN; Grange L; Akanda M; Fox A
Trans Am Ophthalmol Soc; 2017 Aug; 115():T8. PubMed ID: 29576753
[TBL] [Abstract][Full Text] [Related]
2. Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.
Fox AR; Gordon LK; Heckenlively JR; Davis JL; Goldstein DA; Lowder CY; Nussenblatt RB; Butler NJ; Dalal M; Jayasundera T; Smith WM; Lee RW; Adamus G; Chan CC; Hooks JJ; Morgans CW; Detrick B; Sen HN
Am J Ophthalmol; 2016 Aug; 168():183-190. PubMed ID: 27210277
[TBL] [Abstract][Full Text] [Related]
3. Non-paraneoplastic related retinopathy: clinical challenges and review.
Takiuti JT; Takahashi VKL; Xu CL; Jauregui R; Tsang SH
Ophthalmic Genet; 2019 Aug; 40(4):293-297. PubMed ID: 31394964
[TBL] [Abstract][Full Text] [Related]
4. Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema.
Deaner JD; Jaffe GJ; Keenan RT; Carnago L; Grewal DS
Ophthalmol Retina; 2022 Jan; 6(1):91-93. PubMed ID: 34454124
[No Abstract] [Full Text] [Related]
5. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
[TBL] [Abstract][Full Text] [Related]
6. Management of autoimmune retinopathies with immunosuppression.
Ferreyra HA; Jayasundera T; Khan NW; He S; Lu Y; Heckenlively JR
Arch Ophthalmol; 2009 Apr; 127(4):390-7. PubMed ID: 19365013
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune retinopathy.
Grange L; Dalal M; Nussenblatt RB; Sen HN
Am J Ophthalmol; 2014 Feb; 157(2):266-272.e1. PubMed ID: 24315290
[TBL] [Abstract][Full Text] [Related]
8. Consensus on Diagnostic Criteria of Idiopathic Orbital Inflammation Using a Modified Delphi Approach.
Mombaerts I; Bilyk JR; Rose GE; McNab AA; Fay A; Dolman PJ; Allen RC; Devoto MH; Harris GJ;
JAMA Ophthalmol; 2017 Jul; 135(7):769-776. PubMed ID: 28570731
[TBL] [Abstract][Full Text] [Related]
9. Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists.
Lou SM; Larkin KL; Winthrop K; Rosenbaum JT;
Ocul Immunol Inflamm; 2015 Feb; 23(1):25-31. PubMed ID: 25019973
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune retinopathy.
Comlekoglu DU; Thompson IA; Sen HN
Curr Opin Ophthalmol; 2013 Nov; 24(6):598-605. PubMed ID: 24100366
[TBL] [Abstract][Full Text] [Related]
11. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.
Marmor MF; Carr RE; Easterbrook M; Farjo AA; Mieler WF;
Ophthalmology; 2002 Jul; 109(7):1377-82. PubMed ID: 12093666
[No Abstract] [Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. [Chinese expert consensus on the clinical diagnosis and treatment of Vogt-Koyanagi-Harada syndrome (2023)].
;
Zhonghua Yan Ke Za Zhi; 2023 Jul; 59(7):518-525. PubMed ID: 37408422
[TBL] [Abstract][Full Text] [Related]
14. An update on autoimmune retinopathy.
Dutta Majumder P; Marchese A; Pichi F; Garg I; Agarwal A
Indian J Ophthalmol; 2020 Sep; 68(9):1829-1837. PubMed ID: 32823399
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune retinopathy: a review and summary.
Heckenlively JR; Ferreyra HA
Semin Immunopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18408929
[TBL] [Abstract][Full Text] [Related]
16. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
17. The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy.
Finn AP; Thomas AS; Stinnett SS; Keenan RT; Grewal DS; Jaffe GJ
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1867-1873. PubMed ID: 30128606
[TBL] [Abstract][Full Text] [Related]
18. Standardization of OCT Angiography Nomenclature in Retinal Vascular Diseases: First Survey Results.
Munk MR; Kashani AH; Tadayoni R; Korobelnik JF; Wolf S; Pichi F; Tian M
Ophthalmol Retina; 2021 Oct; 5(10):981-990. PubMed ID: 33388471
[TBL] [Abstract][Full Text] [Related]
19. Antireconverin antibodies in ocular chronic graft versus host disease: A new cause of nonparaneoplasic autoimmune retinopathy.
Aguilar González M; Marín Payá E; García Gil R; Feliciano Sánchez A; Gómez-Lechón Quirós L; España Gregori E
Eur J Ophthalmol; 2023 Jul; 33(4):NP105-NP110. PubMed ID: 36052416
[TBL] [Abstract][Full Text] [Related]
20. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference.
Levinson RD; Brezin A; Rothova A; Accorinti M; Holland GN
Am J Ophthalmol; 2006 Jan; 141(1):185-7. PubMed ID: 16386995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
